PARALLEL SESSION 2 // FSHD

4:30 PM • S8L1 • FSHD: Clinical Manifestation and Therapeutic Prospects > R. Rabi TAWIL (Rochester, Usa) 5:00 PM • S8L2 • Decoding DUX4: understanding a trendy landscape of FSHD pathogenesis > A. Alberto ROSA (Cordoba, Argentina) 5:30 PM • S8L3 • Exchange of subtelomeric regions between chromosomes 4q and 10q: a novel way to revert the FSHD genotype and phenotype > A. Anna SCHWAGER (Villejuif, France) 5:45 PM • S8L4 • Targeting muscle degeneration in FSHD: insights from patients’ muscle stem cell niche to unlock disease mechanisms > L. Lorena DI PIETRO (Rome, Italy)